When a traditionally diversified portfolio makes fixed income one of its biggest bets, it’s worth asking what risks it’s ...

According to a filing with the Securities and Exchange Commission dated November 12, Alpine Investment Management opened a new position in Argan(NYSE:AGX), acquiring 60,000 shares valued at $16.20 ...

A small trim can say more about risk management than conviction, and the latest earnings help explain why this position still matters.

In December 2024, Alphabet introduced the world to its newest quantum processing unit, known as Willow. Less than a year ...

I'm confident that Chase Coleman's new Magnificent Seven will outperform the old Magnificent Seven in 2026. I think investors ...

Microsoft has had a successful AI strategy so far. Microsoft's stock carries a premium valuation, but for a good reason. 10 stocks we like better than Microsoft › Fo ...

In 2025, Berkshire added healthcare and cyclicals (including a new stake in UnitedHealth, while paring its megacap tech exposure, including Apple and a major bank.

Cidara Therapeutics develops long-acting anti-infective therapies, with lead products including rezafungin acetate for invasive fungal infections and Cloudbreak platform conjugates targeting viral ...

AQR Capital Management’s Q3 2025 13F portfolio surged to ~$156B. Check out the stake increases and decreases of the portfolio ...

Chicago-based Wishbone Management initiated a new position in EPAM Systems (NYSE:EPAM), buying 100,000 shares valued at $15.08 million, according to a November 13 SEC filing.

Philippe Laffont founded the hedge fund Coatue Management. Coatue's largest positions are in leading artificial intelligence (AI) stocks. Last quarter, Coatue trimmed its exposure to Nvidia and ...